Remegen Co.,Ltd. Posted 1 Billion Yuan Net Loss in First Three Quarters of 2023

Remegen Co.,Ltd. (荣昌生物制药(烟台)股份有限公司) (688331.SH) reported a net loss of 1 billion yuan in the first three quarters of 2023, widening 49.7% year-on-year.

Meanwhile, the company posted 769.5 million yuan in revenue, up 35.1% year-on-year.

At the end of the reporting period, it had 5.5 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 28.3%.